在微血管减压后治疗复发的三角神经疼痛:如何选择
Wenming Lv1, Yanyu Qin2, Xiaoliang Liu3
1First People's Hospital of Ningyang County, Tai'an, Shandong, China; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
概括
对于微血管减压后复发的三角神经疼痛,重复的头骨切除术提供了优越的长期疼痛缓解和较少的并发症,而不是皮肤穿透气球压缩或射频热凝.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 疼痛管理 疼痛管理
背景情况:
- 在微血管减压 (MVD) 后的重复性三角神经疼痛 (TN) 是一个挑战.
- 个性化治疗策略对于管理MVD后TN复发至关重要.
研究的目的:
- 研究MVD后复发性TN患者的治疗策略和临床结果.
- 为了比较重复头骨切除术,皮肤透气球压缩 (PBC) 和射频热凝固 (RFT) 的疗效和安全性.
主要方法:
- 在MVD后复发TN的144名患者的回顾性分析.
- 患者根据治疗进行分类:重复切除术,PBC或RFT.
- 评估的结果包括手术疗效和疼痛复发率.
主要成果:
- 在所有三种治疗方法中,疗效均相似 (P=0.052).
- 重复的头骨切割显示术后并发症显著减少 (P<0.001).
- 虽然1年复发率相似,但重复切除术显示5年复发率明显较低 (P<0.001).
结论:
- 对于MVD后的复发性TN的治疗应根据成像和患者状况进行个性化.
- 重复头骨切割,PBC和RFT都是有效的治疗选择.
- 重复切除术在减少并发症和优越的长期无疼痛复发生存率方面具有优势.
相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...


